Official blog
Compliance-aware guides and brand updates for adult consumers.
Page 18 of 36 / 848 articles
In prisons, cigarettes function as money—a medium of exchange, a store of value, a unit of account. The cigarette's monetary function reveals something profound about nicotine: its value is not just pharmacological. It's social, economic, and deeply human.
Gen Z drinks less, uses fewer drugs, and has less sex than any generation in memory. They're also vaping less than they were five years ago. The youth culture shift is real, it's accelerating, and it challenges every assumption of the 'youth epidemic' narrative.
The tobacco genome was sequenced in 2014. The knowledge it contains—about nicotine biosynthesis, disease resistance, and plant metabolism—could transform tobacco farming, pharmaceutical production, and harm reduction. Most of it has never been applied.
Governments fund smoking cessation programs with one hand and collect tobacco tax revenue with the other. They subsidize tobacco farming while running anti-smoking campaigns. The policy coherence problem is not a bug. It's a structural feature of nicotine governance.
The smoker who says 'we all have to die of something' is not in denial about the health risks. They're employing a psychological defense mechanism that is rational, adaptive, and deeply human. Understanding the death denial is essential to overcoming it.
The most profound challenge of smoking cessation is not pharmacological. It's existential: who are you when the identity you've inhabited for decades is gone? The answer to that question determines whether you stay quit.
The principle 'nothing about us without us' has transformed disability rights, HIV/AIDS advocacy, and mental health policy. It has not reached nicotine. Including nicotine users in the policy process isn't just ethically right—it produces better policies.
The flavor of a nicotine product is not just a sensory experience. It's a memory anchor—a cue that triggers craving, a signal that shapes satisfaction, and a link in the chain of addiction. Understanding flavor memory is essential to designing better cessation tools.
The nicotine industry is investing in sustainability—carbon-neutral manufacturing, biodegradable packaging, ethical supply chains. The investments are real. They're also a strategy for maintaining legitimacy. Is a 'sustainable' nicotine industry possible—or is it a contradiction?
After years of nicotine use, the brain's reward system has been recalibrated: nicotine is the primary source of dopamine, and natural rewards feel muted. The 'dopamine detox' of quitting—the slow relearning of how to experience pleasure without nicotine—is the hardest part of recovery.
Museums are beginning to collect and display cigarette artifacts—packs, advertisements, manufacturing equipment. The curatorial challenge is unprecedented: how do you exhibit an object whose primary significance is the death it caused?
Words like 'epidemic,' 'crisis,' and 'addicted generation' have defined the youth vaping discourse. The language is powerful. It's also inaccurate in ways that distort policy. The words we use to describe youth nicotine use determine the policies we adopt.
In a small factory in Tampa, a handful of elderly Cuban-Americans still hand-roll cigars exactly as they learned in Havana before the Revolution. They are the last practitioners of a dying art. What they know about tobacco, about craft, about work itself is almost gone.
The UK embraced vaping. Australia banned it. Sweden used snus. The US vacillated. Two decades of natural experiments have produced a clear result: the countries that embraced harm reduction have the fastest-declining smoking rates. Is anyone drawing the obvious conclusion?
For many smokers, the cigarette is a social connector—a way to meet people, bond with coworkers, and navigate social situations. When they quit, they lose not just nicotine but a community. The loneliness of quitting is the most underacknowledged barrier.
The missing piece in smoking cessation is not pharmacology. It's ritual design—the creation of new behaviors that serve the same psychological functions as smoking. The future of cessation support is not a better drug. It's a better ritual.
Public health agencies are more afraid of authorizing a product that might cause harm than of failing to authorize a product that could prevent harm. The asymmetry is rational for the agencies. It's lethal for the smokers waiting for better options.
Cloud-chasing—the pursuit of the largest, densest, most aesthetically impressive vapor clouds—was once the center of vaping culture. It's now a niche relic. What it taught us about nicotine satisfaction, community, and identity has been largely forgotten.
The most valuable brand in the history of consumer products—Marlboro—may be reaching the end of its life. Not because smokers are quitting, but because the company that owns it is trying to become something else. The end of Marlboro would be the end of an era.
The default mode network—the brain system active during self-referential thought—is suppressed by nicotine. Smokers spend less time in introspection. Quitting restores the DMN—and the return of self-awareness is one of the most profound and unsettling aspects of recovery.
Western anti-smoking campaigns assume a set of cultural conditions—trust in science, orientation toward the future, individualism—that do not exist in many of the countries where smoking is most prevalent. The message is universal. The audience is not.
The claim 'nicotine harms the developing adolescent brain' has been simplified, amplified, and weaponized in the policy debate. The underlying neuroscience is real—but its policy implications are more nuanced than either side acknowledges. A neuroscientist's view.
Projections of the cigarette's demise range from 2030 (New Zealand's original target) to 'never' (the sober assessment of global health experts). The timeline depends on variables that are political, not scientific—and the politics are shifting faster than anyone predicted.
Cannabis legalization has produced a regulatory model—licensed producers, tracked products, age-gated retail, harm-reduction labeling—that is more sophisticated than anything in nicotine regulation. What would happen if we applied the cannabis model to nicotine?
Products
Select a product to view details, highlights, and technical specifications.
